Today’s pharmaceutical companies are witnessing unprecedented change
driven by a cocktail of competing factors – changing customer demands,
increased global competition, pressures to innovate, hybrid working, supply
chain disruption, regulation compliance and the need to reduce costs – which
are all combining to create a challenging climate.
To that end, this white paper explores the top threats and challenges
pharmaceutical companies must overcome when securing their networks, and
evolving their businesses in this rapidly changing, technologically-driven industry.
We look at the increasing sophistication of cyber threats, the vulnerability of
aging, operational technology environments and the challenges of balancing the
needs of growth with mitigating risk. After all, where there is risk, there can also
be reward but it takes a holistic approach to cyber threats to make that happen.
